These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Catecholamines and neurologic diseases (second of two parts). Moskowitz MA; Wurtman RJ N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386 [No Abstract] [Full Text] [Related]
11. [On the use of phenothiazines in neurology]. Soyka D Med Welt; 1967 Mar; 10():553-6. PubMed ID: 4231369 [No Abstract] [Full Text] [Related]
12. Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Goldman SA Clin Pharmacol Ther; 2007 Oct; 82(4):453-60. PubMed ID: 17713467 [TBL] [Abstract][Full Text] [Related]
13. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309 [TBL] [Abstract][Full Text] [Related]
14. Involuntary movement disorders. Still CN Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089 [TBL] [Abstract][Full Text] [Related]
15. The effect of dietary vitamin B 6 deficiency on the development of the gamma-aminobutyrate shunt in rat brain. Bayoumi RA; Smith WR Biochem J; 1972 May; 127(5):84P-85P. PubMed ID: 5076231 [No Abstract] [Full Text] [Related]
16. [Progress in the treatment of degenerative diseases of the nervous system. Selected problems]. Zaleska B Neurol Neurochir Pol; 1980; 14(2):209-12. PubMed ID: 6446688 [No Abstract] [Full Text] [Related]
17. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease. Mori F; Tanji K; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2012 May; 123(5):747-9. PubMed ID: 22318854 [No Abstract] [Full Text] [Related]
18. Neuropeptides in neurological disease. Beal MF; Martin JB Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536 [TBL] [Abstract][Full Text] [Related]
19. [Alpha- methyl-P-tyrosine effect in extrapyramidal diseases]. Birkmayer W Wien Klin Wochenschr; 1969 Jan; 81(1):10-2. PubMed ID: 4237567 [No Abstract] [Full Text] [Related]
20. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment. Tolosa ES Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195 [No Abstract] [Full Text] [Related] [Next] [New Search]